Healthcare Businesswomen’s Association Names Nikki M. Jones As Chief People and Diversity, Equity, and Inclusion Officer
Jones is credited with improving diversity at the organization.
The Healthcare Businesswomen’s Association (HBA) promoted Nikki M. Jones to the position of Chief People and Diversity, Equity, and Inclusion (DE&I) Officer. Jones, who first started working with the HBA in 2009, started working with the organization to improve its DE&I two years ago and during that time, she has been credited with improving the organization’s diversity and inclusion.
In 2018, the HBA’s staff only had 16% representation for diverse workers. Since then, through the efforts of Jones, that number has risen to 36%. She also worked to improve diversity among the global volunteer membership network, increasing the number of diverse members to 34% from less than 10% several years prior. The honorees at the HBA’s annual Rising Stars and Luminaries award have also become more diverse, with about 40% of them representing diversity.
Jone also launched the HBA’s first Women of Color Wellness Summit and the Honoring Partnerships and Equity program.
Before working with HBA, Jones built up 25 years of experience working in finance and operations. She now leads a 27 person staff and provides guidance for the organization’s 12,000 members.
“Nikki’s passion for the integration of equitable and inclusive practices pushed the association to an official, more committed, and concentrated effort to support and serve women of color and underestimated populations,” said Amy Crolius, Chief Operating Officer, HBA.
Read more about Nikki M. Jones' new position here.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
